Financhill
Back

Plus Therapeutics Quote, Financials, Valuation and Earnings

Plus Therapeutics Price Quote

$1.09

Plus Therapeutics Key Stats

Sell
24
Plus Therapeutics (PSTV) is a Sell

Day range:
$0.97 - $1.11
52-week range:
$0.93 - $2.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.19
P/B ratio:
0%

Volume:
49K
Avg. volume:
84K
1-year change:
-41.4%
Market cap:
$6.4M
Revenue:
$0
EPS:
$-2.53

How Much Does Plus Therapeutics Make?

Data Unavailable

Is Plus Therapeutics Growing As A Company?

Data Unavailable

Plus Therapeutics Stock Price Performance

What Is Plus Therapeutics 52-Week High & Low?

Plus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Plus Therapeutics?

Data Unavailable

Is Plus Therapeutics Cash Flow Positive?

Data Unavailable

Plus Therapeutics Return On Invested Capital

Data Unavailable

Plus Therapeutics Earnings Date & Stock Price

Plus Therapeutics Competitors

  • Who Are Plus Therapeutics's Competitors?
    Below is a list of companies who compete with Plus Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Plus Therapeutics Dividend Yield

Data Unavailable

Plus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 34.22%
Revenue: 0% 28.03%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable